Whalegun
Home

Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 03/04

Trade details

Type
Insider sale
Amount
$1,069,475.6
Shares · price
15,322 sh · $69.80 a share
Held after
768,358 sh
Stock
Halozyme Therapeutics HALO
Person
Helen TorleyPresident and CEO
Trade date
26/03/02
Filed
26/03/04
Days to filing
2 days

Sold 2.0% of holdings

Share of holding sold
2.0%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Helen Torley's recent trades

  • Helen Torley

    Planned sale10b5-1 planHalozyme Therapeutics

    $23.7M

    Filed 08/17

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $1.1M

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $875.6K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $425.1K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $369.2K

    Filed 06/03

Helen Torley, CEO — sold $1.1M of Halozyme Therapeutics HALO · 2.0% of holdings · 10b5-1 plan | Whalegun